tiprankstipranks
Artelo Biosciences Inc (ARTL)
NASDAQ:ARTL
US Market
Want to see ARTL full AI Analyst Report?

Artelo Biosciences (ARTL) Income Statement

579 Followers

Artelo Biosciences Income Statement

Last quarter (Q4 2025), Artelo Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Artelo Biosciences's net income was $-4.17M. See Artelo Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Aug 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 11.40M$ 10.11M$ 9.93M$ 10.29M$ 7.44M
Depreciation and Amortization
$ 146.00K$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -12.54M$ -10.11M$ -9.93M$ -10.08M$ -7.44M
Operating Income
$ -11.40M$ -10.11M$ -9.93M$ -10.29M$ -7.44M
Other Income/Expenses
$ -1.48M$ 282.00K$ 641.00K$ 204.00K$ 4.00K
Pretax Income
$ -12.88M$ -9.83M$ -9.29M$ -10.08M$ -7.44M
Net Income
$ -12.88M$ -9.83M$ -9.29M$ -10.08M$ -7.44M
Per Share Metrics
Basic EPS
$ -5.47$ -1.02$ -1.05$ -1.16$ -1.99
Diluted EPS
$ -5.47$ -1.02$ -1.05$ -1.16$ -1.99
Weighted Average Shares Outstanding
2.36M 9.67M 8.88M 1.42M 622.50K
Weighted Average Shares Outstanding (Diluted)
2.36M 9.67M 8.88M 1.42M 622.50K
Currency in USD

Artelo Biosciences Earnings and Revenue History